{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:16:10Z","timestamp":1782458170033,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO 214"],"award-info":[{"award-number":["KFO 214"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1008-z","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:17:48Z","timestamp":1522801068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Influence of 68Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapy"],"prefix":"10.1186","volume":"13","author":[{"given":"Falk","family":"Stade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Oliver","family":"Dittmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"J\u00e4kel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Kratochwil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"1008_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1748-717X-7-226","volume":"7","author":"SE Combs","year":"2012","unstructured":"Combs SE, Ganswindt U, Foote RL, Kondziolka D, Tonn JC. State-of-the-art treatment alternatives for base of skull meningiomas: complementing and controversial indications for neurosurgery, stereotactic and robotic based radiosurgery or modern fractionated radiation techniques. Radiat Oncol. 2012;7:226.","journal-title":"Radiat Oncol"},{"key":"1008_CR2","doi-asserted-by":"publisher","unstructured":"Kessel KA, Fischer H, Oechnser M, Zimmer C, Meyer B, Combs SE. High-precision radiotherapy for meningiomas: Long-term results and patient-reported outcome (PRO). Strahlenther Onkol. 2017;193(11):921-30. \n                    https:\/\/doi.org\/10.1007\/s00066-017-1156-3\n                    \n                  .","DOI":"10.1007\/s00066-017-1156-3"},{"key":"1008_CR3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.radonc.2012.07.008","volume":"106","author":"SE Combs","year":"2013","unstructured":"Combs SE, Adeberg S, Dittmar JO, Welzel T, Rieken S, Habermehl D, Huber PE, Debus J. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT). Radiother Oncol. 2013;106:186\u201391.","journal-title":"Radiother Oncol"},{"key":"1008_CR4","first-page":"3917","volume":"89","author":"G Lundell","year":"1992","unstructured":"Lundell G, Hall P, Holm LE. Follow the ALARA principle. Lakartidningen. 1992;89:3917.","journal-title":"Lakartidningen"},{"issue":"Suppl 1","key":"1008_CR5","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1007\/s00247-008-1098-0","volume":"39","author":"LE Kun","year":"2009","unstructured":"Kun LE, Beltran C. Radiation therapy for children: evolving technologies in the era of ALARA. Pediatr Radiol. 2009;39(Suppl 1):S65\u201370.","journal-title":"Pediatr Radiol"},{"key":"1008_CR6","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00259-012-2155-3","volume":"39","author":"A Afshar-Oromieh","year":"2012","unstructured":"Afshar-Oromieh A, Giesel FL, Linhart HG, Haberkorn U, Haufe S, Combs SE, Podlesek D, Eisenhut M, Kratochwil C. Detection of cranial meningiomas: comparison of (6)(8)Ga-DOTATOC PET\/CT and contrast-enhanced MRI. Eur J Nucl Med Mol Imaging. 2012;39:1409\u201315.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1008_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijrobp.2005.12.006","volume":"65","author":"S Milker-Zabel","year":"2006","unstructured":"Milker-Zabel S, Zabel-du Bois A, Henze M, Huber P, Schulz-Ertner D, Hoess A, Haberkorn U, Debus J. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys. 2006;65:222\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1008_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijrobp.2012.03.021","volume":"85","author":"R Graf","year":"2013","unstructured":"Graf R, Nyuyki F, Steffen IG, Michel R, Fahdt D, Wust P, Brenner W, Budach V, Wurm R, Plotkin M. Contribution of 68Ga-DOTATOC PET\/CT to target volume delineation of skull base meningiomas treated with stereotactic radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85:68\u201373.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1008_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/978-3-642-27994-2_23","volume":"194","author":"D Thorwarth","year":"2013","unstructured":"Thorwarth D, Muller AC, Pfannenberg C, Beyer T. Combined PET\/MR imaging using (68)Ga-DOTATOC for radiotherapy treatment planning in meningioma patients. Recent Results Cancer Res. 2013;194:425\u201339.","journal-title":"Recent Results Cancer Res"},{"key":"1008_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3109\/0284186X.2013.762996","volume":"52","author":"SE Combs","year":"2013","unstructured":"Combs SE, Welzel T, Habermehl D, Rieken S, Dittmar JO, Kessel K, Jakel O, Haberkorn U, Debus J. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET. Acta Oncol. 2013;52:514\u201320.","journal-title":"Acta Oncol"},{"key":"1008_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-160X-8-1","volume":"8","author":"R Graf","year":"2012","unstructured":"Graf R, Plotkin M, Steffen IG, Wurm R, Wust P, Brenner W, Budach V, Badakhshi H. Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy--a case series. Head Face Med. 2012;8:1.","journal-title":"Head Face Med"},{"key":"1008_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijrobp.2010.10.078","volume":"81","author":"D Thorwarth","year":"2011","unstructured":"Thorwarth D, Henke G, Muller AC, Reimold M, Beyer T, Boss A, Kolb A, Pichler B, Pfannenberg C. Simultaneous 68Ga-DOTATOC-PET\/MRI for IMRT treatment planning for meningioma: first experience. Int J Radiat Oncol Biol Phys. 2011;81:277\u201383.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1008_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s00259-009-1270-2","volume":"37","author":"F Nyuyki","year":"2010","unstructured":"Nyuyki F, Plotkin M, Graf R, Michel R, Steffen I, Denecke T, Geworski L, Fahdt D, Brenner W, Wurm R. Potential impact of (68)Ga-DOTATOC PET\/CT on stereotactic radiotherapy planning of meningiomas. Eur J Nucl Med Mol Imaging. 2010;37:310\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1008_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/neuonc\/nou131","volume":"17","author":"A Afshar-Oromieh","year":"2015","unstructured":"Afshar-Oromieh A, Wolf MB, Kratochwil C, Giesel FL, Combs SE, Dimitrakopoulou-Strauss A, Gnirs R, Roethke MC, Schlemmer HP, Haberkorn U. Comparison of (6)(8)Ga-DOTATOC-PET\/CT and PET\/MRI hybrid systems in patients with cranial meningioma: Initial results. Neuro-Oncology. 2015;17:312\u20139.","journal-title":"Neuro-Oncology"},{"key":"1008_CR15","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3109\/0284186X.2013.818255","volume":"52","author":"SE Combs","year":"2013","unstructured":"Combs SE, Kessel K, Habermehl D, Haberer T, Jakel O, Debus J. Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base. Acta Oncol. 2013;52:1504\u20139.","journal-title":"Acta Oncol"},{"key":"1008_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13014-017-0913-x","volume":"12","author":"JO Dittmar","year":"2017","unstructured":"Dittmar JO, Kratochwil C, Dittmar A, Welzel T, Habermehl D, Rieken S, Giesel FL, Haberkorn U, Debus J, Combs SE. First intraindividual comparison of contrast-enhanced MRI, FET- and DOTATOC- PET in patients with intracranial meningiomas. Radiat Oncol. 2017;12:169.","journal-title":"Radiat Oncol"},{"key":"1008_CR17","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.ijrobp.2009.08.078","volume":"76","author":"C Mayo","year":"2010","unstructured":"Mayo C, Yorke E, Merchant TE. Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys. 2010;76:S36\u201341.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1008_CR18","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.ijrobp.2009.07.1753","volume":"76","author":"C Mayo","year":"2010","unstructured":"Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys. 2010;76:S28\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1008_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3109\/0284186X.2014.973062","volume":"54","author":"L Nkhali","year":"2015","unstructured":"Nkhali L, Thureau S, Edet-Sanson A, Doyeux K, Benyoucef A, Gardin I, Michel P, Vera P, Dubray B. FDG-PET\/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses. Acta Oncol. 2015;54:909\u201315.","journal-title":"Acta Oncol"},{"key":"1008_CR20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s00104-006-1268-2","volume":"77","author":"SE Combs","year":"2006","unstructured":"Combs SE, Schulz-Ertner D, Herfarth KK, Krempien R, Debus J. Advances in radio-oncology. From precision radiotherapy with photons to ion therapy with protons and carbon ions. Chirurg. 2006;77:1126\u201332.","journal-title":"Chirurg"},{"key":"1008_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3389\/fonc.2015.00261","volume":"5","author":"BR Eaton","year":"2015","unstructured":"Eaton BR, MacDonald SM, Yock TI, Tarbell NJ. Secondary Malignancy Risk Following Proton Radiation Therapy. Front Oncol. 2015;5:261.","journal-title":"Front Oncol"},{"key":"1008_CR22","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/HP.0b013e318261113d","volume":"103","author":"H Paganetti","year":"2012","unstructured":"Paganetti H. Assessment of the risk for developing a second malignancy from scattered and secondary radiation in radiation therapy. Health Phys. 2012;103:652\u201361.","journal-title":"Health Phys"},{"key":"1008_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1088\/0031-9155\/57\/2\/499","volume":"57","author":"M Moteabbed","year":"2012","unstructured":"Moteabbed M, Geyer A, Drenkhahn R, Bolch WE, Paganetti H. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy. Phys Med Biol. 2012;57:499\u2013515.","journal-title":"Phys Med Biol"},{"key":"1008_CR24","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1088\/0031-9155\/54\/20\/003","volume":"54","author":"DJ Brenner","year":"2009","unstructured":"Brenner DJ, Elliston CD, Hall EJ, Paganetti H. Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator\/collimator. Phys Med Biol. 2009;54:6065\u201378.","journal-title":"Phys Med Biol"},{"key":"1008_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1667\/RR0527.1","volume":"167","author":"H Suit","year":"2007","unstructured":"Suit H, Goldberg S, Niemierko A, Ancukiewicz M, Hall E, Goitein M, Wong W, Paganetti H. Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat Res. 2007;167:12\u201342.","journal-title":"Radiat Res"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1008-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1008-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1008-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T19:46:41Z","timestamp":1554148001000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1008-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1008"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1008-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]},"assertion":[{"value":"29 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethic\u2019s Committee of the Medical Faculty, University of Heidelberg.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"58"}}